Company Start-Up and Growth Programs
The North Carolina Biotechnology Center's Business and Technology Development Program is focused on driving the start-up and growth of life science companies throughout North Carolina.
Emerging biotech companies require funding from organizations that share their vision. The Center’s Business and Technology Development program provides low-interest loans to promising early-stage biotech companies across the state.
Connecting N.C. Companies with VC/Angel Investors
The Biotechnology Center understands that its grant and loan funding will, in most cases, not be sufficient to move a product from the lab to the market. As such, we lead a number of activities to promote investment in N.C.'s biotechnology companies from external sources. These activities have played a key role in generating more than $100 in subsequent funding for every Biotech Center dollar awarded to North Carolina-based companies.
Corporate Partnering Connections
We connect life sciences companies interested in in-licensing or co-developing products/technologies with North Carolina companies that are developing the next frontier of biotechnology, pharmaceutical, diagnostic, ag biotech and industrial biotechnology products. We also host an annual partnering event that brings together NC-based life science companies with global industry leaders. Partnering 2013 participants included GSK, LabCorp, Lilly, Merck, Novartis, Sanofi, and Syngenta. To discuss your in/out-licensing needs, learn about our partnering event, or plan a visit tailored to your schedule and interests, contact Pamela Fincher at firstname.lastname@example.org.
Technology Transfer and Entrepreneur Programs
We provide a series of programs that specifically serve the entrepreneurial community and university technology transfer offices in the state. These include the BATON Program, the Technology Enhancement Grant, our Pharma-Academic Partnering events, and the Entrepreneurship Essentials series.
Venture Capital and Angel Investor Groups
Venture and angel capital can be a crucial element to the growth of a biotechnology company. See a list of North Carolina-based investment groups that actively invest in emerging life science companies.
Read our Non-Disclosure Policy